Development of epidermal growth factor receptor tyrosine kinase inhibitors against EGFR T790M. Mutation in non small-cell lung carcinoma

Documenti analoghi

• Epidermal growth factor receptor T790M mutation as a prognostic factor in EGFR-mutant non-small cell lung cancer patients that acquired resistance to EGFR tyrosine kinase inhibitors
  di: Ma, Guangzhi, et al.
  Pubblicazione: (2017)
• EGFR tyrosine kinase inhibitor HS-10182 increases radiation sensitivity in non-small cell lung cancers with EGFR T790M mutation
  di: Chen, Yang, et al.
  Pubblicazione: (2018)
• Is T790M mutation the key in development of resistance to epidermal growth factor receptor tyrosine kinase inhibitors (EGFR-TKIs)?
  di: Takabe, Kazuaki
  Pubblicazione: (2011)
• Clinical implication and usefulness of de novo EGFR T790M mutation in lung adenocarcinoma with EGFR-tyrosine kinase inhibitor sensitizing mutation
  di: Lee, Sang Hoon, et al.
  Pubblicazione: (2020)
• A Radiobrominated Tyrosine Kinase Inhibitor for EGFR with L858R/T790M Mutations in Lung Carcinoma
  di: Fawwaz, Muammar, et al.
  Pubblicazione: (2021)